CURCUMIN or turmeric supplementation was associated with a modest but significant reduction in systolic blood pressure in adults with prediabetes or Type 2 diabetes (T2D), according to a new meta-analysis of randomised trials.
CURCUMIN or turmeric supplementation was associated with a modest but significant reduction in systolic blood pressure in adults with prediabetes or Type 2 diabetes (T2D), according to a new meta-analysis of randomised trials.